Michael E. Kilpatrick

1.6k total citations
46 papers, 1.2k citations indexed

About

Michael E. Kilpatrick is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael E. Kilpatrick has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Epidemiology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael E. Kilpatrick's work include Bacterial Infections and Vaccines (6 papers), Parasites and Host Interactions (6 papers) and Salmonella and Campylobacter epidemiology (6 papers). Michael E. Kilpatrick is often cited by papers focused on Bacterial Infections and Vaccines (6 papers), Parasites and Host Interactions (6 papers) and Salmonella and Campylobacter epidemiology (6 papers). Michael E. Kilpatrick collaborates with scholars based in United States, Egypt and Peru. Michael E. Kilpatrick's co-authors include Nabil I. Girgis, Yehia Sultan, Zoheir Farid, Isis A. Mikhail, William O. Harrison, N. I. Girgis, Kannan Krishnan, Michael L. Dourson, Michael Bartels and Monica Nordberg and has published in prestigious journals such as New England Journal of Medicine, Diabetes and American Journal of Epidemiology.

In The Last Decade

Michael E. Kilpatrick

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Kilpatrick United States 17 339 333 329 234 227 46 1.2k
Ronald Altman United States 19 291 0.9× 36 0.1× 199 0.6× 285 1.2× 147 0.6× 35 1.2k
Michael B. Gregg United States 21 509 1.5× 36 0.1× 553 1.7× 288 1.2× 61 0.3× 52 1.8k
Zoheir Farid Egypt 14 190 0.6× 275 0.8× 283 0.9× 99 0.4× 159 0.7× 39 1.1k
Ingeborg S. Aaberge Norway 31 282 0.8× 1.0k 3.1× 1.6k 4.9× 339 1.4× 98 0.4× 95 2.8k
Michael F. Parry United States 23 558 1.6× 187 0.6× 363 1.1× 41 0.2× 135 0.6× 50 1.7k
Rokeya Sultana Rekha Sweden 18 350 1.0× 242 0.7× 246 0.7× 211 0.9× 81 0.4× 31 1.3k
J.P. Thys Belgium 22 307 0.9× 92 0.3× 523 1.6× 38 0.2× 295 1.3× 62 1.3k
Haraldur Bríem Iceland 18 233 0.7× 123 0.4× 252 0.8× 99 0.4× 50 0.2× 51 925
Kamilla D. Lettinga Netherlands 12 161 0.5× 91 0.3× 402 1.2× 103 0.4× 43 0.2× 22 1.2k
C. B. Hall United States 14 606 1.8× 36 0.1× 1.1k 3.5× 127 0.5× 110 0.5× 17 2.0k

Countries citing papers authored by Michael E. Kilpatrick

Since Specialization
Citations

This map shows the geographic impact of Michael E. Kilpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kilpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kilpatrick more than expected).

Fields of papers citing papers by Michael E. Kilpatrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Kilpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kilpatrick. The network helps show where Michael E. Kilpatrick may publish in the future.

Co-authorship network of co-authors of Michael E. Kilpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Kilpatrick. A scholar is included among the top collaborators of Michael E. Kilpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Kilpatrick. Michael E. Kilpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hays, Sean M., Lesa L. Aylward, Judy S. LaKind, et al.. (2008). Guidelines for the derivation of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regulatory Toxicology and Pharmacology. 51(3). S4–S15. 138 indexed citations
2.
LaKind, Judy S., Lesa L. Aylward, Michael L. Dourson, et al.. (2008). Guidelines for the communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regulatory Toxicology and Pharmacology. 51(3). S16–S26. 141 indexed citations
3.
Kilpatrick, Michael E., N. I. Girgis, David R. Tribble, & Farid Zerimech. (1996). The value of the tuberculin skin test in patients with tuberculous meningitis.. PubMed. 71(1-2). 1–8. 8 indexed citations
4.
Watts, Douglas M., et al.. (1993). Prevalence of HIV infection and AIDS in Egypt over four years of surveillance (1986-1990).. PubMed. 96(2). 113–7. 10 indexed citations
5.
Girgis, N. I., et al.. (1993). Meningitis and Encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. American Journal of Tropical Medicine and Hygiene. 48(1). 97–107. 30 indexed citations
6.
Abu‐Elyazeed, Remon, et al.. (1993). Field Trial of 1% Niclosamide as a Topical Antipenetrant to Schistosoma Mansoni Cercariae. American Journal of Tropical Medicine and Hygiene. 49(4). 403–409. 19 indexed citations
7.
Corwin, Andrew L., Douglas M. Watts, James G. Olson, et al.. (1993). Prevalence of antibody to Rift Valley fever virus in the Nile river delta of Egypt, 13 years after a major outbreak. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87(2). 161–161. 9 indexed citations
8.
Kilpatrick, Michael E.. (1993). Diarrhoeal disease—a military perspective. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87. 47–48. 5 indexed citations
9.
Sippel, J E, N. I. Girgis, Michael E. Kilpatrick, & Farid Zand. (1991). Laboratory diagnosis of bacterial meningitis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85. 6–8.
10.
Kilpatrick, Michael E., et al.. (1991). Aztreonam for treating meningitis caused by gram-negative rods. Scandinavian Journal of Infectious Diseases. 23(1). 125–126. 8 indexed citations
11.
Girgis, Nabil I., Zoheir Farid, Michael E. Kilpatrick, Yehia Sultan, & Isis A. Mikhail. (1991). Dexamethasone adjunctive treatment for tuberculous meningitis. The Pediatric Infectious Disease Journal. 10(3). 179–182. 138 indexed citations
12.
Kilpatrick, Michael E., et al.. (1991). A placebo-controlled double-blind trial for the treatment of Bancroftian filariasis with ivermectin or diethylcarbamazine. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85(5). 640–643. 10 indexed citations
13.
Kilpatrick, Michael E., et al.. (1991). Epidemiology, prevalence and clinical diagnosis of meningitis at Abbassia Fever Hospital, Cairo, 1966–1989. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85. 4–5. 6 indexed citations
14.
Zand, Farid, et al.. (1990). Combined praziquantel-oxamniquine treatment of schistosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 84(6). 807–807.
15.
Farid, Zoheir, et al.. (1990). Successful Aztreonam Treatment of Acute Typhoid Fever after Chloramphenicol Failure. Scandinavian Journal of Infectious Diseases. 22(4). 505–506. 6 indexed citations
16.
Girgis, Nabil I., et al.. (1989). Dexamethasone treatment for bacterial meningitis in children and adults. The Pediatric Infectious Disease Journal. 8(12). 848–851. 191 indexed citations
17.
Kilpatrick, Michael E. & Joel Escamilla. (1986). HEPATITIS A IN PERU THE ROLE OF CHILDREN1. American Journal of Epidemiology. 124(1). 111–113. 15 indexed citations
18.
19.
Kilpatrick, Michael E., et al.. (1981). Treatment of Schistosomiasis Mansoni with Oxamniquine—Five Years' Experience. American Journal of Tropical Medicine and Hygiene. 30(6). 1219–1222. 10 indexed citations
20.
Kilpatrick, Michael E., et al.. (1980). Purification of cytoplasmic antigens from the mycelial phase of Candida albicans: Possible advantages of its use in Candida serology. Mycopathologia. 72(1). 47–53. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Altman Breakdown of academic impact, for papers by Michael B. Gregg Breakdown of academic impact, for papers by Zoheir Farid Breakdown of academic impact, for papers by Ingeborg S. Aaberge Breakdown of academic impact, for papers by Michael F. Parry Breakdown of academic impact, for papers by Rokeya Sultana Rekha Breakdown of academic impact, for papers by J.P. Thys Breakdown of academic impact, for papers by Haraldur Bríem Breakdown of academic impact, for papers by Kamilla D. Lettinga Breakdown of academic impact, for papers by C. B. Hall
Rankless by CCL
2026